You are here

Home » Content

Neoplastik şilotoraksın tedavisinde somatostatinin etkis

The effect of somatostatin in the treatment of neoplastic chylothorax

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Chylothorax is the accumulation of lymphatic fluid within the pleural space. Chylothorax can occur in various clinical settings and arise from diverse causes. The optimal management of the patients with chylothorax is still uncertain. Treatment of chylothothorax can be divided into conservative therapy, operative therapy and radiation therapy. Recent reports have suggested that octreotide, by value of its direct action on lymphatic flow, has been useful in resolution of neoplastic chylothorax in the adult population. We herein report prompt cessation of lymphorrhea in an adult patient with chylothorax using octreotide, a long-acting somatostatin analog.
Bookmark/Search this post with
Abstract (Original Language): 
Şilotoraks lenfoid sıvının plevral boşlukta toplanmasıdır. Şilotoraks çok çe- şitli nedenlere bağlı olarak değişik klinik tablolarda ortaya çıkabilir. Şilotorakslı hastaların ideal tedavisi tam olarak belirgin değildir. Şilotoraks tedavisi konservatif tedavi, cerrahi tedavi ve radyoterapi olarak ayrılabilir. Son yayınlar oktreotidin, lenfatik akım üzerine olan direkt etkisi yoluyla erişkinlerde malign şilotoraksın rezolüsyonuna yardımcı olduğunu iddia etmektedir. Biz bu yazıda şilotorakslı erişkin bir hastada uzun etkili bir somatostatin analoğu olan oktreotid ile lenforenin hızla tedavi edilmesini sunuyoruz.
FULL TEXT (PDF): 
PDF icon arastirmax-neoplastik-silotoraksin-tedavisinde-somatostatinin-etkis.pdf
  • 4
251-253
  • English

REFERENCES

References: 

References
1. Dogan R, Demircin M, Dogan OF, Oç M, Kuzgun
E. Effectiveness of somatostatin in the conservative
management of chylothorax. Turk J Pediatr 2004; 46:
262-264.
2. Joseph I, Miller Jr. Anatomy of the thoracic duct and
chylothorax. In: Shields TW (ed). General Thoracic
Surgery. 4th ed. Vol 1. Malvern: Williams&Wilkins,
1994: 714-722.
3. Dixit M, Dubey A, Gan M, et al. Use of Octreotide
in the management of chylothorax – After median
sternotomy. IJTCVS 2005; 21: 285–286.
4. Demos NJ, Kozel J, Scerbo JE. Somatostatin in the
treatment of chylothorax. Chest 2001; 119: 964-966.
5. Doerr CH, Allen MS, Nichols FS, Ryu JH. Etiology of
chylothorax in 203 patients. Mayo Clin Proc 2005; 80:
867-870.
6. Buck ML . Octreotide for the management of chylothorax
in infants and children. Pediatr Pharm 2004; 10.

Thank you for copying data from http://www.arastirmax.com